Scarica l'app Stockscreener
13.08
2.75%
-0.37
Precedente Chiudi:
$13.45
Aprire:
$13.1
Volume 24 ore:
2.65M
Relative Volume:
0.71
Capitalizzazione di mercato:
$1.45B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.4752
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
-7.30%
1M Prestazione:
+8.46%
6M Prestazione:
-12.80%
1 anno Prestazione:
-33.54%
Intervallo 1D:
$12.75
$13.33
Intervallo di 1 settimana:
$12.75
$14.94
Portata 52W:
$6.78
$24.76
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Confronta TXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.08 | 1.66B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
10x Genomics (NASDAQ:TXG) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Options Data Show Bullish Bias in 10x Genomics Inc.Smart Money Tracking Signal Generator Activated - metal.it
When is 10x Genomics Inc. stock expected to show significant growthEntry Signal Forecasts For Consistent Profits - jammulinksnews.com
Building trade automation scripts for 10x Genomics Inc.Low Risk Picks for Daily Trading Released - metal.it
What are analysts’ price targets for 10x Genomics Inc. in the next 12 monthsStock Market Forecasts For 2025 - jammulinksnews.com
10x Genomics Inc. Price Targets Raised After ReboundWeekly Setup With 3x Return Potential Published - metal.it
10x Genomics Inc. Stock Lags Behind Sector BenchmarksInvestment Plan With Growth Optimization Finalized - beatles.ru
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Why 10x Genomics Inc. stock attracts strong analyst attentionReliable Investment Entry Signals Confirmed by Charts - beatles.ru
RSI and MACD Indicate Shift in 10x Genomics Inc. SentimentEntry Alert Based on Volume Spikes Detected - metal.it
AI Trend Models Suggest Bounce for 10x Genomics Inc.Market Entry and Exit Point Tips From Traders - metal.it
Is 10x Genomics Inc. Starting a New UptrendWealth Building Stock Market Ideas Based on Momentum - beatles.ru
Is it the right time to buy 10x Genomics Inc. stockNavigate the market with precision tools - jammulinksnews.com
Short Covering May Lift 10x Genomics Inc. in Near TermSafe Entry Stock Watch Suggestions for Cautious Traders - metal.it
How volatile is 10x Genomics Inc. stock compared to the marketValue Investing Tracker To Watch Now - jammulinksnews.com
What are 10x Genomics Inc. company’s key revenue driversOutstanding capital appreciation - jammulinksnews.com
What is 10x Genomics Inc. company’s growth strategyTrack stocks with high upside potential easily - jammulinksnews.com
What catalysts could drive 10x Genomics Inc. stock higher in 2025Market Forecast Planner To Watch Now - jammulinksnews.com
Why 10x Genomics Inc. stock attracts strong analyst attention Technical Screener for High Growth Stocks - metal.it
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Is 10x Genomics Inc. a growth stock or a value stockBest Dividend Report With High Returns - jammulinksnews.com
What is the risk reward ratio of investing in 10x Genomics Inc. stockUnrivaled growth potential - jammulinksnews.com
What institutional investors are buying 10x Genomics Inc. stockUnlock exclusive stock market insights - jammulinksnews.com
What drives 10x Genomics Inc. stock priceRecord-setting profit potential - PrintWeekIndia
What analysts say about 10x Genomics Inc. stockAccelerated investment success - PrintWeekIndia
Is 10x Genomics Inc. a good long term investmentSpectacular growth rates - Autocar Professional
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - TradingView
10x Genomics Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10 X Genomics Inc Azioni (TXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | See Remarks |
May 22 '25 |
Sale |
8.30 |
7,485 |
62,120 |
448,374 |
| Taich Adam | Chief Financial Officer |
May 22 '25 |
Sale |
8.30 |
4,044 |
33,562 |
331,588 |
0.98%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):